ReplimuneJPMorganHealthcareConference2025Presentation

Igniting a systemic immune response to cancer with oncolytic immunotherapyJP Morgan Healthcare ConferenceJanuary 13, 20252JP Morgan Healthcare Conference© 2025 Replimune Group Inc.Safe HarborAnystatementscontainedhereinthatarenotstatementsofhistoricalfactsmaybedeemedtobeforward-lookingstatementswithinthemeaningofSection27AoftheSecuritiesActof1933,asamended,andSection21EoftheSecuritiesExchangeActof1934,asamended,includingstatementsregardingtheadvancement,timingandsufficiencyofourclinicaltrialsorfinancialstatus,patientenrollmentsinourexistingandplannedclinicaltrialsandthetimingthereof,theresultsofourclinicaltrials,thetimingandreleaseofourclinicaldata,statementsregardingourexpectationsaboutourcashrunway,ourgoalstodevelopandcommercializeourproductcandidates,ourexpectationsregardingthesizeofthepatientpopulationsforourproductcandidatesifapprovedforcommercialuseandotherstatementsidentifiedbywordssuchas“could,”“expects,”“intends,”“may,”“plans,”“potential,”“should,”“will,”“would,”orsimilarexpre